A randomized controlled clinical trial of combination therapy for type 2 diabetes by vildagliptin, metformin, and α-glucosidase inhibitor
Crossref DOI link: https://doi.org/10.1007/s13410-015-0388-y
Published Online: 2015-06-17
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Qiong
Su, Yong
Lv, Lifang
Text and Data Mining valid from 2015-06-17